SMTL ID : 9df2.1

EGFR Exon20 insertion mutant ASV bound with (S)-3-((3-chloro-2-methoxyphenyl)amino)-2-(3-((tetrahydrofuran-2-yl)methoxy)pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

monomer

Ligands

1 x 01: 3-[(3-chloranyl-2-methoxy-phenyl)amino]-2-[3-[[(2S)-oxolan-2-yl]methoxy]pyridin-4-yl]-1,5,6,7-tetrahydropyrrolo[3,2-c]pyridin-4-one

01.1: 21 residues within 4Å: Chain A: L.26, F.31, V.34, A.51, I.52, K.53, E.70, M.74, L.88, L.99, T.101, Q.102, L.103, M.104, G.107, C.108, R.152, N.153, L.155, T.165, D.166 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:L.26, A:F.31, A:F.31, A:K.53, A:L.99, A:T.101, A:L.155, A:T.165 Hydrogen bonds: A:K.53, A:M.104, A:T.165, A:T.165, A:D.166, A:D.166

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.2: 3 residues within 4Å: Chain A: I.189, K.190 Ligands: EDO.5 Ligand excluded by PLIP

6 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.3: 3 residues within 4Å: Chain A: H.84, Q.160, H.161 No protein-ligand interaction detected (PLIP) EDO.4: 5 residues within 4Å: Chain A: E.242, R.243, P.245, Y.255, R.259 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:R.243, A:R.243, A:Y.255 Water bridges: A:Q.246 EDO.5: 3 residues within 4Å: Chain A: R.152, P.188 Ligands: CL.2 1 PLIP interactions: 1 interactions with chain A Water bridges: A:R.152 EDO.6: 7 residues within 4Å: Chain A: A.182, V.187, M.192, S.196, I.197, R.200, Y.202 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:I.197 EDO.7: 8 residues within 4Å: Chain A: M.74, V.77, V.80, N.82, V.85, C.86, R.87, Y.138 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:M.74, A:N.82, A:N.82 EDO.8: 4 residues within 4Å: Chain A: C.108, L.110, D.111, R.152 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:D.111

4 x GOL: GLYCEROL(Non-functional Binders)

GOL.9: 2 residues within 4Å: Chain A: M.263 Ligands: GOL.11 No protein-ligand interaction detected (PLIP) GOL.10: 5 residues within 4Å: Chain A: T.251, I.252, D.253, R.288, Y.289 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:T.251, A:T.251, A:D.253, A:D.253 GOL.11: 6 residues within 4Å: Chain A: G.241, R.243, R.259, W.262, M.263 Ligands: GOL.9 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:G.241, A:R.259, A:R.259 Water bridges: A:R.243, A:R.243 GOL.12: 6 residues within 4Å: Chain A: D.267, S.268, R.269, P.270, K.271, E.274 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:S.268, A:K.271

1 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)

PEG.13: 7 residues within 4Å: Chain A: A.30, F.31, K.53, E.66, E.70, D.166, G.168 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:K.53, A:K.53, A:G.168

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Pagliarini, R.A. et al., STX-721, a covalent EGFR/HER2 exon 20 inhibitor, takes advantage of exon 20 mutant dynamic protein states and achieves unique mutant-selectivity across human cancer models. To Be Published

Release Date

2025-05-14

Peptides

Epidermal growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Epidermal growth factor receptor